• 文献标题:   Graphene oxide-metal oxide nanocomposites for on-target enrichment and analysis of phosphorylated biomolecules
  • 文献类型:   Article
  • 作  者:   JABEEN F, SAJID MS, FATIMA B, SAEED A, ASHIQ MN, NAJAMULHAQ M
  • 作者关键词:   graphene oxide, lanthanide metal oxide, ontarget enrichment, phospholipid, phosphopeptide
  • 出版物名称:   JOURNAL OF SEPARATION SCIENCE
  • ISSN:   1615-9306 EI 1615-9314
  • 通讯作者地址:  
  • 被引频次:   5
  • DOI:   10.1002/jssc.202001276 EA JUL 2021
  • 出版年:   2021

▎ 摘  要

The surface of matrix-assisted laser desorption/ionization mass spectrometry target is modified for improved signal strength and detection of analytes. The developed method includes on-target enrichment and detection of phosphopeptides/phospholipids using graphene oxide-lanthanide metal oxides (samarium, gadolinium, dysprosium, and erbium) nanocomposites. Enriched phosphopeptides are detected using material enhanced laser desorption/ionization mass spectrometry and phospholipids by laser desorption/ionization-mass spectrometry. Nanocomposites are prepared using graphene oxide with respective metal salts at high pH. They are characterized for nano-morphology, chemistry, porosity, composition, crystallinity, and thermal stability. Phosphopeptides enrichment protocol is developed and optimized for tryptic beta-casein digest and that of phospholipids by phosphatidylcholine standard. Statistical analyses of phosphopeptides and phospholipids from milk show overlapping results for gadolinium, dysprosium, and erbium oxide nanocomposites. GO-Gd2O3 has better enrichment efficiency and application as LDI material. Selectivity for GO-Dy2O3 is 1:2500, for GO-Sm2O3 is 1:3500, and 1:4000 for GO-Gd2O3. GO-Er2O3 has a sensitivity of 25 fmol, whereas the highest sensitivity is down to 0.5 fmol for GO-Gd2O3. On-target enrichment is batch to batch reproducible with a standard deviation of <1, reduced time of enrichment to 10 min, and ease of operation compared to solid-phase batch extraction. The developed method enriches serum phosphopeptides characteristic of cancer-related phosphoproteins.